CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes-Reference-Cited by-同舟云学术

CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes

Published:2017-11 Issue: Volume:382 Page:91-95
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Constantinides Vasilios C.^ORCID,Paraskevas George P.,Emmanouilidou Evangelia,Petropoulou Olga,Bougea Anastasia,Vekrellis Kostas,Evdokimidis Ioannis,Stamboulis Eleftherios,Kapaki Elisabeth

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference30 articles.

1. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases;Hughes;J. Neurol. Neurosurg. Psychiatry,1992

2. Accuracy of clinical diagnosis of progressive supranuclear palsy;Osaki;Mov. Disord.,2004

3. A validation exercise on the new consensus criteria for multiple system atrophy;Osaki;Mov. Disord.,2009

4. Does corticobasal degeneration exist? A clinicopathological re-evaluation;Ling;Brain,2010

5. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;McKhann;Alzheimers Dement.,2011

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy;Brain Sciences;2024-08-26

2. Biomarker-Based Precision Therapy for Alzheimer’s Disease: Multidimensional Evidence Leading a New Breakthrough in Personalized Medicine;Journal of Clinical Medicine;2024-08-08

3. Cerebrospinal Fluid Total and Phosphorylated Tau Protein in Behavioral Variant Frontotemporal Dementia, Progressive Supranuclear Palsy, Corticobasal Syndrome and Non-Fluent Agrammatic Primary Progressive Aphasia: A Systematic Review and Meta-Analysis;Biomedicines;2024-08-06

4. Serum Oligomeric α-Synuclein and p-tau181 in Progressive Supranuclear Palsy and Parkinson’s Disease;International Journal of Molecular Sciences;2024-06-23

5. Evaluating the Effect of Alzheimer's Disease‐Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy;Annals of Neurology;2024-04-05